136 related articles for article (PubMed ID: 4888928)
1. Blood group antigens in virus vaccines.
Franks D; Dawson A
Natl Cancer Inst Monogr; 1968 Dec; 29():195-9. PubMed ID: 4888928
[No Abstract] [Full Text] [Related]
2. Virus-associated gain and loss of proliferative and neoplastic properties of normal and virus-transformed diploid cell lines.
Yerganian G; Nell MA; Cho SS; Hayford AH; Ho T
Natl Cancer Inst Monogr; 1968 Dec; 29():241-68. PubMed ID: 4306757
[No Abstract] [Full Text] [Related]
3. [Isoantigens of human leukocytes and their significance in biology and medicine].
Khundanov LL; Verbitskiĭ MSh; Portnoĭ VF; Shatalova IN
Usp Sovrem Biol; 1971; 71(3):460-81. PubMed ID: 4938088
[No Abstract] [Full Text] [Related]
4. Tissue and medium antigens in vaccines.
Coriell LL
Natl Cancer Inst Monogr; 1968 Dec; 29():179-91. PubMed ID: 4976862
[No Abstract] [Full Text] [Related]
5. Characteristics of cell culture systems: viral flora of tissue sources and tissue and medium antigens in vaccines--summary.
Sigel MM; von Magnus H
Natl Cancer Inst Monogr; 1968 Dec; 29():551-4. PubMed ID: 4976867
[No Abstract] [Full Text] [Related]
6. Viral flora of tissue sources and tissue and medium antigens in vaccines--general comments.
Vasington PJ
Natl Cancer Inst Monogr; 1968 Dec; 29():205-6. PubMed ID: 4976358
[No Abstract] [Full Text] [Related]
7. Viral flora of tissue sources and tissue and medium antigens in vaccines--general comments.
Fellowes ON
Natl Cancer Inst Monogr; 1968 Dec; 29():209-14. PubMed ID: 5720794
[No Abstract] [Full Text] [Related]
8. Viral flora of tissue sources and tissue and medium antigens in vaccines--general comments.
Jensen KE
Natl Cancer Inst Monogr; 1968 Dec; 29():207-8. PubMed ID: 5720793
[No Abstract] [Full Text] [Related]
9. Latent viral infections in donor tissues and in recipients of vaccines.
Melnick JL
Natl Cancer Inst Monogr; 1968 Dec; 29():337-49. PubMed ID: 4305432
[No Abstract] [Full Text] [Related]
10. Cell cultures for virus vaccine production. General conclusions from the conference.
Merchant DJ
Natl Cancer Inst Monogr; 1968 Dec; 29():583-4. PubMed ID: 5720811
[No Abstract] [Full Text] [Related]
11. Neoplastic properties of animal cell lines. Methods for determining neoplastic properties--discussion.
Dawe CJ
Natl Cancer Inst Monogr; 1968 Dec; 29():229-32. PubMed ID: 5720795
[No Abstract] [Full Text] [Related]
12. Industrial production of primary tissue culture.
Warren J
Natl Cancer Inst Monogr; 1968 Dec; 29():35-43. PubMed ID: 4976363
[No Abstract] [Full Text] [Related]
13. Evidence for oncogenic properties of heteroploid cell lines--discussion.
Moore AE
Natl Cancer Inst Monogr; 1968 Dec; 29():291-2. PubMed ID: 4890060
[No Abstract] [Full Text] [Related]
14. Viral flora of primate tissues--discussion.
Malherbe H
Natl Cancer Inst Monogr; 1968 Dec; 29():177-8. PubMed ID: 5720790
[No Abstract] [Full Text] [Related]
15. Viral oncogenicity and viral vaccines--general comments.
Gerber P
Natl Cancer Inst Monogr; 1968 Dec; 29():447-8. PubMed ID: 4888932
[No Abstract] [Full Text] [Related]
16. Tissue and medium antigens in vaccines--discussion.
Feldman HA
Natl Cancer Inst Monogr; 1968 Dec; 29():193-4. PubMed ID: 5720791
[No Abstract] [Full Text] [Related]
17. Viral oncogenicity and virus vaccines--summary.
Habel K; Murphy WH
Natl Cancer Inst Monogr; 1968 Dec; 29():561-3. PubMed ID: 5713331
[No Abstract] [Full Text] [Related]
18. Tissue cell cultivation--general comments.
Pirt SJ
Natl Cancer Inst Monogr; 1968 Dec; 29():93-6. PubMed ID: 5720815
[No Abstract] [Full Text] [Related]
19. Evidence for oncogenic properties of primary cultures.
Defendi V
Natl Cancer Inst Monogr; 1968 Dec; 29():269-70. PubMed ID: 5720796
[No Abstract] [Full Text] [Related]
20. Evidence for oncogenic properties of heteroploidy cell lines.
Sanford KK
Natl Cancer Inst Monogr; 1968 Dec; 29():283-7. PubMed ID: 5720798
[No Abstract] [Full Text] [Related]
[Next] [New Search]
